Ambarella [AMBA] vs Onto Innovation [ONTO] Detailed Stock Comparison
Ambarella
NASDAQ
Loading...
Onto Innovation
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ambarella wins in 4 metrics, Onto Innovation wins in 14 metrics, with 0 ties. Onto Innovation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ambarella | Onto Innovation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -23.32 | 26.62 | Ambarella |
| Price-to-Book Ratio | 5.05 | 2.68 | Onto Innovation |
| Debt-to-Equity Ratio | 0.77 | 0.68 | Onto Innovation |
| PEG Ratio | 0.62 | -0.75 | Onto Innovation |
| EV/EBITDA | -25.93 | 16.53 | Ambarella |
| Profit Margin (TTM) | -32.73% | 19.29% | Onto Innovation |
| Operating Margin (TTM) | -30.11% | 19.10% | Onto Innovation |
| EBITDA Margin (TTM) | N/A | 19.10% | N/A |
| Return on Equity | -18.35% | 10.53% | Onto Innovation |
| Return on Assets (TTM) | -10.54% | 6.31% | Onto Innovation |
| Free Cash Flow (TTM) | $23.46M | $213.77M | Onto Innovation |
| 1-Year Return | 32.38% | -50.48% | Ambarella |
| Price-to-Sales Ratio (TTM) | 9.14 | 5.09 | Onto Innovation |
| Enterprise Value | $2.59B | $4.39B | Onto Innovation |
| EV/Revenue Ratio | 8.18 | 4.24 | Onto Innovation |
| Gross Profit Margin (TTM) | 60.01% | 48.16% | Ambarella |
| Revenue per Share (TTM) | $8 | $21 | Onto Innovation |
| Earnings per Share (Diluted) | $-2.49 | $4.04 | Onto Innovation |
| Beta (Stock Volatility) | 2.08 | 1.44 | Onto Innovation |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ambarella vs Onto Innovation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ambarella | 9.04% | -3.73% | -5.35% | 3.82% | -15.58% | -10.90% |
| Onto Innovation | 2.87% | -4.15% | 5.84% | 11.46% | -33.86% | -38.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ambarella | 32.38% | -21.70% | 26.94% | -31.45% | 959.71% | 959.71% |
| Onto Innovation | -50.48% | 38.54% | 229.36% | 220.26% | 220.26% | 220.26% |
Performance & Financial Health Analysis: Ambarella vs Onto Innovation
| Metric | AMBA | ONTO |
|---|---|---|
| Market Information | ||
| Market Cap | $2.89B | $5.27B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 442,248 | 1,851,590 |
| 90 Day Avg. Volume | 521,106 | 1,331,770 |
| Last Close | $71.99 | $108.49 |
| 52 Week Range | $38.86 - $85.15 | $85.88 - $228.42 |
| % from 52W High | -15.46% | -52.50% |
| All-Time High | $227.59 (Nov 29, 2021) | $238.93 (Jul 15, 2024) |
| % from All-Time High | -68.37% | -54.59% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.58% | 0.05% |
| Quarterly Earnings Growth | 0.58% | -0.36% |
| Financial Health | ||
| Profit Margin (TTM) | -0.33% | 0.19% |
| Operating Margin (TTM) | -0.30% | 0.19% |
| Return on Equity (TTM) | -0.18% | 0.11% |
| Debt to Equity (MRQ) | 0.77 | 0.68 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.50 | $40.12 |
| Cash per Share (MRQ) | $6.12 | $18.26 |
| Operating Cash Flow (TTM) | $63.59M | $273.17M |
| Levered Free Cash Flow (TTM) | $90.96M | $187.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Ambarella vs Onto Innovation
| Metric | AMBA | ONTO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -23.32 | 26.62 |
| Forward P/E | -378.67 | 16.03 |
| PEG Ratio | 0.62 | -0.75 |
| Price to Sales (TTM) | 9.14 | 5.09 |
| Price to Book (MRQ) | 5.05 | 2.68 |
| Market Capitalization | ||
| Market Capitalization | $2.89B | $5.27B |
| Enterprise Value | $2.59B | $4.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.18 | 4.24 |
| Enterprise to EBITDA | -25.93 | 16.53 |
| Risk & Other Metrics | ||
| Beta | 2.08 | 1.44 |
| Book Value per Share (MRQ) | $13.50 | $40.12 |
Financial Statements Comparison: Ambarella vs Onto Innovation
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMBA | ONTO |
|---|---|---|
| Revenue/Sales | $85.87M | $253.60M |
| Cost of Goods Sold | $34.34M | $131.48M |
| Gross Profit | $51.54M | $122.12M |
| Research & Development | $58.82M | $35.29M |
| Operating Income (EBIT) | $-25.86M | $38.47M |
| EBITDA | $-19.11M | $60.13M |
| Pre-Tax Income | $-23.68M | $39.74M |
| Income Tax | $645,000 | $5.83M |
| Net Income (Profit) | $-24.33M | $33.91M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMBA | ONTO |
|---|---|---|
| Cash & Equivalents | $141.29M | $203.73M |
| Total Current Assets | $335.55M | $1.47B |
| Total Current Liabilities | $124.85M | $174.48M |
| Long-Term Debt | $2.06M | $8.66M |
| Total Shareholders Equity | $572.72M | $1.92B |
| Retained Earnings | $-276.39M | $671.12M |
| Property, Plant & Equipment | $13.06M | $13.49M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMBA | ONTO |
|---|---|---|
| Operating Cash Flow | $15.43M | $81.15M |
| Capital Expenditures | $-4.57M | $-8.23M |
| Free Cash Flow | $10.24M | $83.75M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-1.00M | $-75.02M |
Short Interest & Institutional Ownership Analysis
| Metric | AMBA | ONTO |
|---|---|---|
| Shares Short | 2.17M | 2.12M |
| Short Ratio | 3.58 | 2.06 |
| Short % of Float | 0.06% | 0.06% |
| Average Daily Volume (10 Day) | 442,248 | 1,851,590 |
| Average Daily Volume (90 Day) | 521,106 | 1,331,770 |
| Shares Outstanding | 41.96M | 49.24M |
| Float Shares | 39.87M | 48.60M |
| % Held by Insiders | 0.05% | 0.01% |
| % Held by Institutions | 0.89% | 1.03% |
Dividend Analysis & Yield Comparison: Ambarella vs Onto Innovation
| Metric | AMBA | ONTO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |